Overview

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Alpha-fetoprotein Levels on the Response to direct Antiviral Therapy in Patients with Chronic Hepatitis C
Phase:
Phase 4
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Antiviral Agents
Ledipasvir
Ledipasvir, sofosbuvir drug combination
Sofosbuvir